Skip to main content

WHO confirmed Remdesiver has no impact on coronavirus patients


Two drugs Remdesivir and Hydroxychloroquine are getting popular after the eruption of pandemic virus in the world. Though the actual vaccine not ready for coronavirus, many countries relay on two drugs temporarily to fight with coronavirus. 

Countries like United States and Brazil request India for the supply of Hydroxychloroquine, malaria drug which is believed to increase immunity in human beings. World Health Organization (WHO) has found that Anti-viral drug Remdesvir has little or no impact on covid-19 patients.


It is ridiculous that WHO revealed the facts 8 months after the coronavirus eruption. The WHO trial evaluated four potential medications for Covid-19, including Remdesivir and Hydroxychloroquine. Trials on Hydroxychloroquine and Lopinavir/Ritonavir have stopped in June because they had already proven ineffective. The four drugs were tested with 11,266 adult patients in total, across 500 hospitals in more than 30 different countries. WHO came to conclusion on Remdesivir was tested in a clinical trial conducted by its scientists. Remdesivir is anti-viral drug that was recently used to treat US President Donald Trump.


Meanwhile, Gilead claimed that Remdesivir cut covid-19 recovery time by 5 days in a trial conducted by it on 1062 patients. The drug received emergency use authorization from the US Food and Drug Administration on May 1. Gilead Sciences has dismissed the WHO findings in a statement. It said that WHO data appears inconsistent. Chinese vaccine has shown promising results. BBIBP-CorV, developed by Chinese Pharma Company has triggered immune responses in early and later stages of human trials. As per WHO, BBIBP-CorV is one of the 10 coronavirus projects in Phase III trials. WHO also certified that Chinese vaccine doesn’t show any side-effects on humans in trials. 

Comments

Popular posts from this blog

Photo : Savitri during her last days

Even after 4 decades of her death, people are very much interested to watched her (Savitri) biopic. Mahanati turned to be stupendous success. On eve of remembering Savitri, here we posted Savitri photo. The photo seems her last days. The man stand behind Savitri is Gemini Ganeshan who married Savitri. It seems that she suffered bad days during her last days.

Jagan angry on Avanthi Srinivas on Bhimili meeting!

Avanthi Srinivas was joined in YSRCP in January this year. Avanthi joined in YSRCP seeking to contest as Bhimili Assembly segment in 2019 General Elections.

Producers demand 18 crores for Ceded for Pavan and Trivikram film

Director Rajamouli showed the path to all other producers on how to sell product (movie) in different ways across the word. Telugu Cinema has vertically divided in two ways Before and after Bahubali. Bahubali proves that there were no boundaries in selling the movie. Other producers who are doing with star heros like Pavan, Mahesh and Jr. NTR will follow Rajamouli in this regard. But there is slight difference with Bahubali and other heros films. Unfortunately, producers and distributors fail to notice the gap. Bahubali is universal movie which was apt to all sections in the world. That is the reason for getting huge collections across the world. We didn't expect the same situation for Prabas's next movie even though his popularity increased with Bahubali. Radha Krishna who produced movies like Julayi and A. AA.. will plan to produce next film with Pavan and Trivikram. Movie was not yet started but distributors rushed toward producer for getting area-wise rights.Obviously, ...